SP
CME icon

Saranac Partners’s CME Group CME Stock Holding History

Saranac Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Buy
+1,590
New +$440K 0.1% 89

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Saranac Partners's CME Position: Q2 2026 in Review

Saranac Partners opened a new position in CME Group (CME) in Q2 2026: 1,590 shares worth $351K. The stake represents 0.1% of the portfolio and ranks #89 among its holdings.

1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Saranac Partners held 1,590 shares of CME Group worth $351K as of Q2 2026.
  • CME Group was a new Saranac Partners position in Q2 2026.
  • CME Group made up 0.1% of Saranac Partners's portfolio in Q2 2026, its #89 holding.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Saranac Partners's 13F filing for Q2 2026, filed 13 Aug 2026.